Your browser doesn't support javascript.
loading
MHC class I antigen cross-presentation mediated by PapMV nanoparticles in human antigen-presenting cells is dependent on autophagy.
Possamaï, David; Hanafi, Laïla-Aïcha; Bellemare-Pelletier, Angélique; Hamelin, Katia; Thébault, Paméla; Hébert, Marie-Josée; Gagnon, Étienne; Leclerc, Denis; Lapointe, Réjean.
Affiliation
  • Possamaï D; Centre de recherche du Centre hospitalier de l'Université de Montréal, Montréal, Québec, Canada.
  • Hanafi LA; Centre de recherche du Centre hospitalier de l'Université de Montréal, Montréal, Québec, Canada.
  • Bellemare-Pelletier A; Institut de Recherche en Immunologie et Cancérologie, Montréal, Québec, Canada.
  • Hamelin K; Département de Microbiologie et Immunologie, Université de Montréal, Montréal, Québec, Canada.
  • Thébault P; Centre de recherche du Centre hospitalier de l'Université de Montréal, Montréal, Québec, Canada.
  • Hébert MJ; Centre de recherche du Centre hospitalier de l'Université de Montréal, Montréal, Québec, Canada.
  • Gagnon É; Centre de recherche du Centre hospitalier de l'Université de Montréal, Montréal, Québec, Canada.
  • Leclerc D; Institut de Recherche en Immunologie et Cancérologie, Montréal, Québec, Canada.
  • Lapointe R; Département de Microbiologie et Immunologie, Université de Montréal, Montréal, Québec, Canada.
PLoS One ; 16(12): e0261987, 2021.
Article in En | MEDLINE | ID: mdl-34972158
Nanoparticles made of the coat protein of papaya mosaic virus (PapMV) and a single-strand RNA were previously shown to be an efficient antigen presentation system for the trigger of cellular immunity. Engineering of PapMV nano with a cytotoxic T lymphocyte epitope was previously shown activating specific T lymphocytes through a proteasome-independent major histocompatibility complex class I (MHC-I) cross-presentation. In this study, we provide new insights into the mechanism of the MHC-I cross-presentation mediated by PapMV nanoparticles. We demonstrate that PapMV nanoparticles do not require the transporter associated with antigen presentation (TAP), but rather depend on lysosome acidification and cathepsin S protease activity for presentation of the T cell epitope. We have also linked the induction of autophagy with this vacuolar MHC-I cross-presentation process. Interestingly, autophagy is induced in antigen-presenting cells after PapMV nanoparticles exposure and inhibition of autophagy reduce MHC-I cross-presentation. This study demonstrates that autophagy is associated with TAP- and proteasome-independent MHC-I cross-presentation. A deeper understanding of the autophagy-dependent MHC-I cross-presentation will be useful in designing vaccination platforms that aim to trigger an efficient cytotoxic T lymphocyte response.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autophagy / Histocompatibility Antigens Class I / Antigen Presentation / Cross-Priming / Antigen-Presenting Cells Limits: Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2021 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autophagy / Histocompatibility Antigens Class I / Antigen Presentation / Cross-Priming / Antigen-Presenting Cells Limits: Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2021 Document type: Article Affiliation country: Country of publication: